Determination of deferasirox plasma concentrations: do gender, physical and genetic differences affect chelation efficacy?-Reference-Cited by-同舟云学术

Determination of deferasirox plasma concentrations: do gender, physical and genetic differences affect chelation efficacy?

Published:2014-09-17 Issue:4 Volume:94 Page:310-317
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Mattioli Francesca¹,Puntoni Matteo²,Marini Valeria¹,Fucile Carmen¹,Milano Giulia¹,Robbiano Luigi¹,Perrotta Silverio³,Pinto Valeria⁴,Martelli Antonietta¹,Forni Gian Luca⁴

Affiliation:

1. Department of Internal Medicine; Clinical Pharmacology and Toxicology Unit; University of Genoa; Genoa Italy

2. Clinical Trial Unit; Scientific Directorate; E.O. Galliera; Genoa Italy

3. Department of Pediatrics; Second University of Naples; Naples Italy

4. SSD Ematologia - Centro della Microcitemia E.O. Galliera; Genoa Italy

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12419/fullpdf

Reference23 articles.

1. Iron-chelating therapy and the treatment of thalassemia;Olivieri;Blood,1997

2. Deferasirox for managing iron overload in people with thalassaemia;Meerpohl;Cochrane Database Syst Rev,2012

3. Pharmacokinetics, metabolism, and disposition of deferasirox in β-Thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state;Waldmeier;Drug Metab Dispos,2010

4. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia;Cappellini;Blood,2006

5. Effect of food, type of food, and time of food intake on deferasirox bioavailability: recommendations for an optimal deferasirox administration regimen;Galanello;J Clin Pharmacol,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crosstalk between ferroptosis and chondrocytes in osteoarthritis: a systematic review of in vivo and in vitro studies;Frontiers in Immunology;2023-07-14

2. Genetic polymorphisms influencing deferasirox pharmacokinetics, efficacy, and adverse drug reactions: a systematic review and meta-analysis;Frontiers in Pharmacology;2023-05-16

3. Effect of Aging on Deferasirox Therapy in Transfusion-dependent Patients. A Prospective- Retrospective, Cohort-study;Current Drug Metabolism;2022-11

4. Iron Chelators in Treatment of Iron Overload;Journal of Toxicology;2022-05-05

5. Evaluation of Pharmacokinetics and Pharmacodynamics of Deferasirox in Pediatric Patients;Pharmaceutics;2021-08-11